© 1997 American Heart Association, Inc.
Articles |
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
From the Department of Epidemiology and Public Health, Agricultural University, Wageningen (P.V., F.J.K., E.G.S.); Zuiderziekenhuis Hospital, Rotterdam (D.A.C.M.K.); and the Department of Epidemiology and Biostatistics, Erasmus University Medical School (J.C.M.W., D.E.G.), Rotterdam, The Netherlands; and the Department of Clinical Biology, Division of Pharmacology, University of Bergen (P.M.U., H.R.), Norway.
Correspondence to Dr Petra Verhoef, Department of Epidemiology and Public Health, Agricultural University, PO Box 238, 6700 AE, Wageningen, The Netherlands. E-mail petra.verhoef{at}medew.hegl.wau.nl
Abstract Epidemiological research has shown that elevated plasma total homocysteine (tHcy) is a risk factor for atherosclerotic disease. In the present case-control study, we investigated whether fasting or postmethionine-loading tHcy was a stronger predictor of risk of severe coronary atherosclerosis. Furthermore, we studied levels of B vitamins, which are involved in homocysteine metabolism. Subjects were recruited from men and women, aged 25 to 65 years, who underwent coronary angiography between June 1992 and June 1994 in a hospital in Rotterdam, The Netherlands. Cases (n=131) were defined as those with 
90% occlusion in one and 40% occlusion in a second coronary artery, while control subjects (n=88) had 
50% occlusion in only one coronary vessel. In addition, a population-based control group free from clinical cardiovascular disease (n=101) was studied. Coronary patients were studied at least 2.5 months after angiography or other acute illness, such as myocardial infarction. After adjusting for age and sex differences between the groups, cases had 9% (P=.01) higher geometric mean fasting and 7% (P=.04) higher geometric mean postload tHcy than the combined control groups. Despite higher levels of tHcy for cases, their geometric mean levels of red cell folate and pyridoxal 5'-phosphate were higher than for control subjects, whereas plasma vitamin B12 was only slightly lower in cases. The frequency distribution of tHcy values in cases was slightly shifted toward the right, across the entire range, compared with the distribution in the combined control group. This was somewhat more obvious for fasting than postload tHcy levels. The odds ratio (OR) for severe coronary atherosclerosis (case status) for each 1 SD increase in fasting tHcy (5 µmol/L) was 1.3 (95% confidence interval [CI], 1.0-1.6), similar to the OR for each 1 SD increase (12 µmol/L) in postmethionine-loading tHcy (1.3 [95 CI, 1.0-1.7]), after adjustment for sex, age, and other potential confounders. Furthermore, there was a significant linear trend of increasing fasting tHcy with increasing number of occluded arteries (P=.01), correcting for sex, age, and other potential confounders. Our data show a positive association between plasma tHcy and risk of severe coronary atherosclerosis, of similar strength for fasting and postload tHcy levels. The data suggest that the association exists over a wide range of tHcy levels, without a clear cutoff point below which there is no increased risk.
Key Words: plasma total homocysteine • vitamins • risk factor • coronary atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  S. K. Park, M. S. O'Neill, P. S. Vokonas, D. Sparrow, A. Spiro III, K. L. Tucker, H. Suh, H. Hu, and J. Schwartz Traffic-related Particles Are Associated with Elevated Homocysteine: The VA Normative Aging Study Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dierkes, C. Weikert, K. Klipstein-Grobusch, S. Westphal, C. Luley, M. Mohlig, J. Spranger, and H. Boeing Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort Am. J. Clinical Nutrition, July 1, 2007; 86(1): 214 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vanuzzo, L. Pilotto, R. Lombardi, G. Lazzerini, M. Carluccio, S. Diviacco, F. Quadrifoglio, G. Danek, D. Gregori, P. Fioretti, et al. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects Eur. Heart J., February 2, 2007; 28(4): 484 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R Olthof, E. J Brink, M. B Katan, and P. Verhoef Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men Am. J. Clinical Nutrition, July 1, 2005; 82(1): 111 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, M. Zanchetta, A. Burlina, L. Pedon, G. Maiolino, D. Sticchi, A. C. Pessina, and G. P. Rossi Hyperhomocysteinemia Is Inversely Related With Left Ventricular Ejection Fraction and Predicts Cardiovascular Mortality in High-Risk Coronary Artery Disease Hypertensives Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Bleie, H. Refsum, P. M. Ueland, S. E. Vollset, A. B. Guttormsen, E. Nexo, J. Schneede, J. E. Nordrehaug, and O. Nygard Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention Am. J. Clinical Nutrition, September 1, 2004; 80(3): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vrentzos, J. A. Papadakis, N. Malliaraki, E. A. Zacharis, K. Katsogridakis, A. N. Margioris, P. E. Vardas, and E. S. Ganotakis Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort Angiology, September 1, 2004; 55(5): 517 - 524. [Abstract] [PDF]
|
|
|
|
|
|
E. Bozkurt, S. Keles, M. Acikel, M. Islek, and S. Atesal Plasma Homocysteine Level and the Angiographic Extent of Coronary Artery Disease Angiology, May 1, 2004; 55(3): 265 - 270. [Abstract] [PDF]
|
|
|
|
 |
|
 M. R. Olthof, T. van Vliet, E. Boelsma, and P. Verhoef Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine in Healthy Men and Women J. Nutr., December 1, 2003; 133(12): 4135 - 4138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I Mennen, G. P. de Courcy, J.-C. Guilland, V. Ducros, M. Zarebska, S. Bertrais, A. Favier, S. Hercberg, and P. Galan Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study Am. J. Clinical Nutrition, August 1, 2003; 78(2): 334 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Steenge, P. Verhoef, and M. B. Katan Betaine Supplementation Lowers Plasma Homocysteine in Healthy Men and Women J. Nutr., May 1, 2003; 133(5): 1291 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]
|
|
|
|
 |
|
 U. Lim and P. A. Cassano Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Bree, W. M. Verschuren, D. Kromhout, L. I Mennen, H. J Blom, E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, et al. Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects Int. J. Epidemiol., December 1, 2002; 31(6): 1268 - 1272. [Full Text] [PDF]
|
|
|
|
 |
|
 Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J.A. Lievers, L. A. Afman, L. A.J. Kluijtmans, G. H.J. Boers, P. Verhoef, M. den Heijer, F. J.M. Trijbels, and H. J. Blom Polymorphisms in the Transcobalamin Gene: Association with Plasma Homocysteine in Healthy Individuals and Vascular Disease Patients Clin. Chem., September 1, 2002; 48(9): 1383 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]
|
|
|
|
|
|
B. N Ames, I. Elson-Schwab, and E. A Silver High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms Am. J. Clinical Nutrition, April 1, 2002; 75(4): 616 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R Dimitrova, K. DeGroot, A. K Myers, and Y. D Kim Estrogen and homocysteine Cardiovasc Res, February 15, 2002; 53(3): 577 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. van der Griend, D. H Biesma, and J.-D. Banga Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens Vascular Medicine, February 1, 2002; 7(1): 29 - 33. [Abstract] [PDF]
|
|
|
|
|
|
E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, X. Jiang, F. Yang, G. B. Chapman, W. Durante, N. E. S. Sibinga, and A. I. Schafer Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition Blood, February 1, 2002; 99(3): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Verhaar, E. Stroes, and T.J. Rabelink Folates and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 6 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mueller, B. Furtmueller, J. Aigelsdorfer, C. Luft, W. Poelz, and M. Haltmayer Total serum homocysteine - a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease Vascular Medicine, August 1, 2001; 6(3): 163 - 167. [Abstract] [PDF]
|
|
|
|
|
|
A. de Bree, W. M. Verschuren, H. J Blom, and D. Kromhout Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y Am. J. Clinical Nutrition, June 1, 2001; 73(6): 1027 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. A. Witte, A. L. Clark, and J. G. F. Cleland Chronic heart failure and micronutrients J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1765 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Koehler, R. N Baumgartner, P. J Garry, R. H Allen, S. P Stabler, and E. B Rimm Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use Am. J. Clinical Nutrition, March 1, 2001; 73(3): 628 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Appel, E. R. Miller III, S. H. Jee, R. Stolzenberg-Solomon, RD, P.-H. Lin, T. Erlinger, M. R. Nadeau, and J. Selhub Effect of Dietary Patterns on Serum Homocysteine : Results of a Randomized, Controlled Feeding Study Circulation, August 22, 2000; 102(8): 852 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Brattstrom and D. E. Wilcken Homocysteine and cardiovascular disease: cause or effect? Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Krumdieck and C. W. Prince Mechanisms of Homocysteine Toxicity on Connective Tissues: Implications for the Morbidity of Aging J. Nutr., February 1, 2000; 130(2): 365 - 365. [Abstract] [Full Text]
|
|
|
|
|
|
L. El-Khairy, P. M Ueland, O. Nygard, H. Refsum, and S. E Vollset Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study Am. J. Clinical Nutrition, December 1, 1999; 70(6): 1016 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. W. Eikelboom, E. Lonn, J. Genest Jr., G. Hankey, and S. Yusuf Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence Ann Intern Med, September 7, 1999; 131(5): 363 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Ungvari, P. Pacher, K. Rischak, L. Szollar, and A. Koller Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced Hyperhomocysteinemia Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1899 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kristensen, J. Malm, T. K. Nilsson, J. Hultdin, B. Carlberg, G. Dahlen, and T. Olsson Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic Stroke Stroke, May 1, 1999; 30(5): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Borson-Chazot, C. Harthe, F. Teboul, F. Labrousse, C. Gaume, L. Guadagnino, B. Claustrat, F. Berthezene, and P. Moulin Occurrence of Hyperhomocysteinemia 1 Year after Gastroplasty for Severe Obesity J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 541 - 545. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Siri, P. Verhoef, and F. J. Kok Vitamins B6, B12, and Folate: Association with Plasma Total Homocysteine and Risk of Coronary Atherosclerosis J. Am. Coll. Nutr., October 1, 1998; 17(5): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Jacobsen Homocysteine and vitamins in cardiovascular disease Clin. Chem., August 1, 1998; 44(8): 1833 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Folsom, F. J. Nieto, P. G. McGovern, M. Y. Tsai, M. R. Malinow, J. H. Eckfeldt, D. L. Hess, and C. E. Davis Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins : The Atherosclerosis Risk in Communities (ARIC) Study Circulation, July 21, 1998; 98(3): 204 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. J. Brouwer, H. T. M. E. Welten, D.-J. Reijngoud, J. J. van Doormaal, and F. A. J. Muskiet Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine Clin. Chem., July 1, 1998; 44(7): 1545 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Omenn, S. A. A. Beresford, and A. G. Motulsky Preventing Coronary Heart Disease : B Vitamins and Homocysteine Circulation, February 10, 1998; 97(5): 421 - 424. [Full Text] [PDF]
|
|
|
|
|
|
E. K. Hoogeveen, P. J. Kostense, P. J. Beks, A. J. C. Mackaay, C. Jakobs, L. M. Bouter, R. J. Heine, and C. D. A. Stehouwer Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus : A Population-Based Study Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 133 - 138. [Abstract] [Full Text] [PDF]
|
|